CN114269724A - 放射性金属络合物的制造方法 - Google Patents

放射性金属络合物的制造方法 Download PDF

Info

Publication number
CN114269724A
CN114269724A CN202080058291.3A CN202080058291A CN114269724A CN 114269724 A CN114269724 A CN 114269724A CN 202080058291 A CN202080058291 A CN 202080058291A CN 114269724 A CN114269724 A CN 114269724A
Authority
CN
China
Prior art keywords
radioactive metal
ligand
water
metal complex
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080058291.3A
Other languages
English (en)
Chinese (zh)
Inventor
今井智之
桐生真登
井泽彰宏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Medi Physics Co Ltd
Original Assignee
Nihon Medi Physics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Medi Physics Co Ltd filed Critical Nihon Medi Physics Co Ltd
Publication of CN114269724A publication Critical patent/CN114269724A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
    • C07F19/005—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00 without metal-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/003—Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CN202080058291.3A 2019-08-21 2020-08-04 放射性金属络合物的制造方法 Pending CN114269724A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019-151480 2019-08-21
JP2019151480 2019-08-21
PCT/JP2020/029757 WO2021033530A1 (ja) 2019-08-21 2020-08-04 放射性金属錯体の製造方法

Publications (1)

Publication Number Publication Date
CN114269724A true CN114269724A (zh) 2022-04-01

Family

ID=74660922

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080058291.3A Pending CN114269724A (zh) 2019-08-21 2020-08-04 放射性金属络合物的制造方法

Country Status (9)

Country Link
US (1) US20220259160A1 (https=)
EP (1) EP4019502A4 (https=)
JP (2) JP7744828B2 (https=)
KR (1) KR20220047974A (https=)
CN (1) CN114269724A (https=)
AU (1) AU2020332618A1 (https=)
CA (1) CA3148288A1 (https=)
TW (1) TW202120483A (https=)
WO (1) WO2021033530A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022149578A1 (ja) 2021-01-08 2022-07-14 日本メジフィジックス株式会社 Ａｃ－２２５溶液の製造方法およびＡｃ－２２５溶液を用いた医薬の製造方法
EP4442285A1 (en) 2021-11-30 2024-10-09 Nihon Medi-Physics Co., Ltd. Stabilized radiopharmaceutical composition

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002067999A2 (en) * 2001-02-28 2002-09-06 Dow Global Technologies Inc. Actinium-225 complexes and conjugates for targeted radiotherapy
WO2005084179A2 (en) * 2003-12-01 2005-09-15 Immunomedics, Inc. Improved method for preparing conjugates of proteins and chelating agents
CN102123739A (zh) * 2007-12-19 2011-07-13 免疫医疗公司 用于蛋白质、肽和其他分子的改进的f-18标记方法和组合物
WO2015084996A1 (en) * 2013-12-03 2015-06-11 Millennium Pharmaceuticals, Inc. Compounds and compositions for imaging gcc-expressing cells
WO2018187631A1 (en) * 2017-04-05 2018-10-11 Cornell University Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008009444A1 (en) * 2006-07-19 2008-01-24 Van Dulmen, Adrianus, A. Use of ethanol for stabilizing a single-vial liquid formulation of a radiolabeled peptide
AU2010326004B2 (en) * 2009-12-04 2016-04-21 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
DE102012019714B4 (de) * 2012-10-08 2022-04-28 Johannes Gutenberg-Universität Mainz Verfahren zur Herstellung von pharmakologischen Metall-Ligand-Konjugaten
US20140147381A1 (en) * 2012-11-29 2014-05-29 Gregory David Espenan 89zr compounds, to include somatostatin, apparatus and products comprising such compounds, methods of making same, and methods of using same for radio imaging and/or treatment
WO2017161356A1 (en) * 2016-03-18 2017-09-21 Wake Forest University Compounds, compositions and associated methods using zirconium-89 in immuno-positron emission tomography
JP2019151480A (ja) 2018-03-06 2019-09-12 富士ゼロックス株式会社 検知装置及び画像形成装置
US12351890B2 (en) * 2019-07-30 2025-07-08 Jfe Engineering Corporation Method for synthesizing zirconium complex

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002067999A2 (en) * 2001-02-28 2002-09-06 Dow Global Technologies Inc. Actinium-225 complexes and conjugates for targeted radiotherapy
WO2005084179A2 (en) * 2003-12-01 2005-09-15 Immunomedics, Inc. Improved method for preparing conjugates of proteins and chelating agents
CN102123739A (zh) * 2007-12-19 2011-07-13 免疫医疗公司 用于蛋白质、肽和其他分子的改进的f-18标记方法和组合物
WO2015084996A1 (en) * 2013-12-03 2015-06-11 Millennium Pharmaceuticals, Inc. Compounds and compositions for imaging gcc-expressing cells
WO2018187631A1 (en) * 2017-04-05 2018-10-11 Cornell University Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANCHAL GHAI ET AL.: ""Optimizing the radiosynthesis of [68Ga]DOTA-MLN6907 peptide containing three disulfide cyclization bonds – a GCC specific chelate for clinical radiopharmaceuticals"", 《APPLIED RADIATION AND ISOTOPES》, vol. 140, 9 August 2018 (2018-08-09), pages 333 - 341, XP055803251, DOI: 10.1016/j.apradiso.2018.08.006 *
KOKI HASEGAWA ET AL.: ""Improved 68Ga‐labeling method using ethanol addition: Application to the α‐helical peptide DOTA‐FAMP"", 《J LABEL COMPD RADIOPHARM》, vol. 60, 31 December 2017 (2017-12-31), pages 55 - 61, XP055803249, DOI: 10.1002/jlcr.3474 *
MARYLAINE PÉREZ-MALO ET AL.: ""Improved Efficacy of Synthesizing *MIII-Labeled DOTA Complexes in Binary Mixtures of Water and Organic Solvents. A Combined Radio-and Physicochemical Study"", 《INORGANIC CHEMISTRY》, vol. 57, 10 May 2018 (2018-05-10), pages 6107 - 6117 *

Also Published As

Publication number Publication date
EP4019502A1 (en) 2022-06-29
JP7744828B2 (ja) 2025-09-26
US20220259160A1 (en) 2022-08-18
CA3148288A1 (en) 2021-02-25
EP4019502A4 (en) 2023-08-16
TW202120483A (zh) 2021-06-01
JP2025116040A (ja) 2025-08-07
JPWO2021033530A1 (https=) 2021-02-25
AU2020332618A1 (en) 2022-02-24
WO2021033530A1 (ja) 2021-02-25
KR20220047974A (ko) 2022-04-19

Similar Documents

Publication Publication Date Title
Notni et al. A triazacyclononane‐based bifunctional phosphinate ligand for the preparation of multimeric 68Ga tracers for positron emission tomography
Shetty et al. Stable aluminium fluoride chelates with triazacyclononane derivatives proved by X-ray crystallography and 18 F-labeling study
JP2025116040A (ja) 放射性金属錯体の製造方法
US20080267868A1 (en) Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex
US5409689A (en) MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms
WO1993008839A1 (en) Multifunctional ligands for potential use in the design of therapeutic or diagnostic radiopharmaceutical imaging agents
JP3097755B2 (ja) 遷移金属の窒化物錯体の製造方法
Lipowska et al. fac-99mTc/Re-tricarbonyl complexes with tridentate aminocarboxyphosphonate ligands: Suitability of the phosphonate group in chelate ligand design of new imaging agents
Bollinger et al. Complexation of indium (III), gallium (III), iron (III), gadolinium (III), and neodymium (III) ions with amino diphosphonic acids in aqueous solution
JP6525968B2 (ja) トランス−ジ−ｎ−ピコリネートテトラアザシクロアルカンベースの鉛（ｉｉ）およびビスマス（ｉｉｉ）のキレート
JPH0222286A (ja) テクネチウム−９９ｍの陽イオン錯体を製造するためのリガンド
Försterová et al. Chemical and biological evaluation of 153Sm and 166Ho complexes of 1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetrakis (methylphosphonic acid monoethylester)(H4dotpOEt)
JPH11504002A (ja) 診断医薬品及び治療医薬品としての使用のためのヒドロキシアルキルホスフィン化合物並びにその製造方法
Lipowska et al. Monoanionic 99mTc-tricarbonyl-aminopolycarboxylate complexes with uncharged pendant groups: radiosynthesis and evaluation as potential renal tubular tracers
AU2001276677A1 (en) Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex
JPH04120066A (ja) １０−（２’−ヒドロキシ−３’−ポリオキサアルキル）−１，４，７−トリスカルボキシメチル−１，４，７，１０−テトラアザシクロドデカン
Gano et al. Radiolanthanide complexes with tetraazamacrocycles bearing methylphosphonate pendant arms as bone seeking agents
CN1232525C (zh) 99TcmN二巯基丁二酸类化合物、其制备方法和其在核医学上的应用
HK40066248A (zh) 放射性金属络合物的制造方法
O'Callaghan et al. Synthesis and properties of metal trifluoride complexes with amide-functionalised tacn macrocycles and radiofluorination of [GaF 3 (L1)] by 18 F/19 F isotopic exchange
JP7773990B2 (ja) 放射性ジルコニウム錯体の製造方法
JPH06505975A (ja) 環状リガンド
Hayes Technetium-99m carbonyl complexes and new ligand development for targeted radiopharmaceuticals
CN105175454B (zh) 一种99mTcN核标记阿仑膦酸氨荒酸盐配合物及制备方法和应用
Zhang et al. Synthesis and biodistribution in mice of a new 99mTc nitrido complex for brain imaging

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40066248

Country of ref document: HK

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20220401